Non-Invasive Prenatal Testing in Germany

被引:8
|
作者
Liehr, Thomas [1 ]
Harutyunyan, Tigran [2 ]
Williams, Heather [3 ]
Weise, Anja [1 ]
机构
[1] Friedrich Schiller Univ, Jena Univ Hosp, Inst Human Genet, D-07747 Jena, Germany
[2] Yerevan State Univ, Dept Genet & Cytol, Yerevan 0001, Armenia
[3] Tempus Labs Inc, Chicago, IL 60654 USA
关键词
first trimester-screening (FTS); teratogen effects; multigenetic diseases; pregnant woman perspective; false-positive; false-negative; knowledge of specialists and public; RISK; DNA; AMNIOCENTESIS; ANEUPLOIDIES; CHALLENGES; TRISOMY-13; DIAGNOSIS; UPDATE; CELLS;
D O I
10.3390/diagnostics12112816
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In the short 10 years following the introduction of non-invasive prenatal testing (NIPT), it has been adapted in many countries around the world as a standard screening test. In this review, this development was analyzed with a special focus on Germany. As a result, it can be stated that all known advantages of NIPT apart from "compensating for having no access to centers offering invasive diagnostics" are valid for Germany. In addition, following a review of the international literature, all documented issues with NIPT are also observed in Germany. However, the German Gene Diagnostics Act (GenDG) addresses a number of these issues, for example, the regulations by GenDG hamper induced abortions, based exclusively on an abnormal NIPT result. At the same time, GenDG has created new problems, as a possible collusion between the "right not to know with regard to parts of the examination result" may occur, or that the sex of the fetus must not be reported to the pregnant woman before the 12th week of gestation. Main conclusions drawn are that appropriate training and the continuing education of the physicians providing NIPT-related counseling are needed, as well as the provision of balanced and comprehensive information for the pregnant woman or the couple that is imperative.
引用
下载
收藏
页数:11
相关论文
共 50 条
  • [31] Non-invasive prenatal testing (NIPT): is routinization problematic?
    Christoph Rehmann-Sutter
    Daniëlle R. M. Timmermans
    Aviad Raz
    BMC Medical Ethics, 24
  • [32] Non-Invasive Prenatal Testing In Pregnancy In An Irish Cohort
    Traynor, B.
    McCarthy, F.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2020, 189 (SUPPL 4) : 34 - 34
  • [33] Non-invasive prenatal testing (NIPT) - state of the art
    Lo, Y. M. D.
    HUMAN REPRODUCTION, 2017, 32 : 1 - 2
  • [34] Questioning the costs and benefits of non-invasive prenatal testing
    Stoll, Katie
    Lutgendorf, Monica
    Knutzen, Dana
    Nielsen, Peter E.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (06): : 633 - 634
  • [35] Uptake of non-invasive prenatal testing by Japanese women
    Akaishi, R.
    Yamada, T.
    Kawaguchi, S.
    Kojima, T.
    Koyama, T.
    Umazume, T.
    Morikawa, M.
    Cho, K.
    Minakami, H.
    ULTRASOUND IN OBSTETRICS & GYNECOLOGY, 2015, 45 (01) : 113 - 114
  • [36] Non-invasive Prenatal Testing Using Fetal DNA
    Giulia Breveglieri
    Elisabetta D’Aversa
    Alessia Finotti
    Monica Borgatti
    Molecular Diagnosis & Therapy, 2019, 23 : 291 - 299
  • [37] Clinical utility and cost of non-invasive prenatal testing
    Cuckle, Howard
    Benn, Peter
    Pergament, Eugene
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2014, 27 (03): : 320 - 321
  • [38] Indications for invasive prenatal testing before and after implementation of non-invasive prenatal screening
    Gill, Lisa
    Prosen, Tracy L.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2017, 216 (01) : S126 - S127
  • [39] Advancements of non-invasive prenatal testing: the role of obstetricians
    Eltabbakh, Nada
    Mohasin, Yalnaz
    Jeddy, Rafiea
    FRONTIERS IN MEDICINE, 2024, 11
  • [40] The implementation of non-invasive prenatal testing (NIPT) in the Netherlands
    Bilardo, Caterina M.
    JOURNAL OF PERINATAL MEDICINE, 2021, 49 (08) : 941 - 944